Acesso livre
Acesso livre

Arquivos do dia: Junho 21, 2022

Relatório da OMS destaca necessidade urgente de transformar a saúde mental.

21 Jun, 2022 | 13:17h

Comunicado de imprensa: WHO highlights urgent need to transform mental health and mental health care – World Health Organization

Relatório: World mental health report: Transforming mental health for all – World Health Organization

Comentário: Urgent Need to Transform Mental Health Care – WHO Says In Largest Review Ever – Health Policy Watch

 

Comentário no Twitter (fio – clique para saber mais)

 

Atualização da OMS sobre o surto de varíola dos macacos.

21 Jun, 2022 | 13:15h

Multi-country monkeypox outbreak: situation update – World Health Organization

Conteúdos relacionados:

Monkeypox Genital Lesions – New England Journal of Medicine

Monkeypox: Africa CDC Demands Equal Treatment in Global Allocation of Limited Vaccine Doses – Health Policy Watch

Monkeypox vaccination begins — can the global outbreaks be contained? – Nature

Incubation period for monkeypox: Estimates from the Netherlands.

‘Discriminatory and stigmatizing’: Scientists push to rename monkeypox viruses – STAT

Rename monkeypox strains to remove geographic stigma, researchers say – Science

Clinical management and infection prevention and control for monkeypox: Interim rapid response guidance, 10 June 2022 – World Health Organization

2022 Monkeypox and Orthopoxvirus Outbreak Global Map – Centers for Disease Control and Prevention

As monkeypox threat grows, scientists debate best vaccine strategy – Science

Monkeypox is a new global threat. African scientists know what the world is up against – Science

WHO Experts Emphasize ‘Window of Opportunity’ to Control Monkeypox Spread as Cases Outside Africa Double Again – Health Policy Watch

Genetic data indicate at least two separate monkeypox outbreaks underway, suggesting wider spread – STAT

Experts highlight sexual aspect of monkeypox spread – CIDRAP

What to Know About Monkeypox – JAMA

Multi-country monkeypox outbreak in non-endemic countries: Update – World Health Organization

Principles for monkeypox control in the UK: 4 nations consensus statement – UK Health Security Agency

Monkeypox outbreaks: 4 key questions researchers have – Nature

Study reports first use of antivirals in monkeypox patients – Lancet

Surveillance, case investigation and contact tracing for Monkeypox – World Health Organization

Laboratory testing for the monkeypox virus: Interim guidance – World Health Organization

A Novel International Monkeypox Outbreak – Annals of Internal Medicine

EU health agency warns monkeypox could become endemic in Europe if outbreak continues – STAT

Monkeypox cases increase across Europe, North America – CIDRAP

Multi-country monkeypox outbreak in non-endemic countries – World Health Organization

Monkeypox goes global: why scientists are on alert – Nature

Monkeypox: What do we know about the outbreaks in Europe and North America? – The BMJ

Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – STAT

What is monkeypox? A microbiologist explains what’s known about this smallpox cousin – The Conversation

Monkeypox: Time to worry or one to ignore? – BBC

UK, Spain, Portugal report more monkeypox cases – CIDRAP

U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak – STAT

Monkeypox – United Kingdom of Great Britain and Northern Ireland – World Health Organization

Monkeypox cases confirmed in England – latest updates – UK Health Security Agency

Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – Health Policy Watch

European outbreak of monkeypox: what you need to know – The Conversation

Rare monkeypox outbreak in U.K., Europe and U.S.: What is it and should we worry – NPR

Monkeypox cases under investigation in Canada as outbreak spreads in Europe, U.S. – CBC News

Estudo randomizado | Uma estratégia de restrição de fluidos intravenosos não melhora os desfechos em pacientes em UTI com choque séptico.

21 Jun, 2022 | 13:14h

Restriction of Intravenous Fluid in ICU Patients with Septic Shock – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentário: No Fewer Deaths Seen With Restricted IV Fluid for Septic Shock – HealthDay

Conteúdos relacionados:

Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery – New England Journal of Medicine

Effect of Slower vs Faster Intravenous Fluid Bolus Rates on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial – JAMA

Fluid administration and monitoring in ARDS: which management? – Intensive Care Medicine

Perioperative liberal versus restrictive fluid strategies and postoperative outcomes: a systematic review and metanalysis on randomised-controlled trials in major abdominal elective surgery – Critical Care

 

Comentário no Twitter

 

Diretriz provisória da OMS sobre o uso de vacinas contra COVID-19 atualizadas para as variantes.

21 Jun, 2022 | 13:12h

Interim statement on decision-making considerations for the use of variant updated COVID-19 vaccines – World Health Organization

Ver também: Interim statement on the composition of current COVID-19 vaccines – World Health Organization

 

Comentário no Twitter (fio – clique para saber mais)

 

Opinião | Normalizando a menopausa – “Martha Hickey e colaboradores argumentam que atitudes culturais e sociais contribuem para que a menopausa seja experienciada de maneira variada e que a medicalização alimenta percepções negativas.”

21 Jun, 2022 | 13:10h

Normalizing menopause – The BMJ (gratuito por tempo limitado)

Comunicado de imprensa: Medicalizing menopause may be unhelpful for some women – British Medical Journal

Comentário: Menopause is not a disease. Experts call for new narrative for this natural stage of a woman’s life – CNN

Estudo de coorte | Associação entre níveis de gamaglutamiltransferase e desfechos de mortalidade total, relacionados ao fígado e cardiovasculares.

21 Jun, 2022 | 13:08h

Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank – eClinicalMedicine

 

Comentário no Twitter

Sob licença de CC BY-NC-ND 4.0

Estudo de caso-controle | Risco de COVID longa associado com variantes Delta vs. Ômicron do SARS-CoV-2.

21 Jun, 2022 | 13:06h

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 – The Lancet

Comunicado de imprensa: Long COVID risk less during Omicron compared to Delta, study finds – King’s College London

Comentários:

Expert reaction to study looking at long COVID prevalence associated with delta versus omicron variants of SARS-CoV-2 – Science Media Centre

Omicron less likely to lead to long COVID, study finds – CIDRAP

Covid-19: Long covid risk is lower with omicron than delta, researchers find – The BMJ

 

Comentário no Twitter

 

Estudo de consenso | Estabelecido de desfechos para a condição pós-COVID-19 para uso na prática clínica e em pesquisas.

21 Jun, 2022 | 13:05h

A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study – The Lancet Respiratory Medicine

Comunicado de imprensa: Key outcomes of Long COVID identified in international consensus study – King’s College London

Comentário convidado: Post-COVID-19 condition in children: a COS is urgently needed – The Lancet Respiratory Medicine

 

Comentário no Twitter

 

Dicas para Covid longa: cientistas se esforçam para desvendar o que determina os sintomas incapacitantes.

21 Jun, 2022 | 13:03h

Clues To Long Covid – Science

[Preprint] Estudo randomizado aberto | Baricitinibe é não inferior ao tocilizumabe em pacientes internados com COVID-19 grave.

21 Jun, 2022 | 13:01h

Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial – medRxiv

Conteúdos relacionados:

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial – The Lancet Respiratory Medicine

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis – medRxiv

WHO recommends two new drugs to treat COVID-19 – World Health Organization

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial – The Lancet Respiratory Medicine

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 – New England Journal of Medicine

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.